Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Cerevel Therapeutics Holdings, Inc. (CERE)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and CERE | ||
|---|---|---|
| S&P 500 | CERE | |
| Start Date | Nov-01-2020 | Nov-30-2020 |
| Start Price | $2,476.46 | $14.12 |
| End Date | May-01-2024 | May-17-2024 |
| End Price | $5,018.39 | $42.10 |
| Number Monthly Prices | 43 | 43 |
| Min Date | Oct-01-2022 | Jan-29-2021 |
| Min Price | $3,897.91 | $12.87 |
| Max Date | Apr-01-2024 | Apr-30-2024 |
| Max Price | $5,243.77 | $42.71 |
| Total Return | 18.03% | 198.16% |
| Annualized Return | 4.74% | 35.65% |
| Current Value of $1,000 Purchase | $1,180 | $2,982 |
| Number Returns | 903 | 903 |
| Average Return | -0.03% | 41.22% |
| Minimum Return | -25.54% | -46.30% |
| Maximum Return | 34.53% | 231.86% |
| Number Profitable Returns | 460 | 634 |
| Percent Profitable Returns | 50.94% | 70.21% |
| Number Unprofitable Returns | 443 | 269 |
| Percent Unprofitable Returns | 49.06% | 29.79% |
| Profitable to Unprofitable Returns Ratio | 1.04 | 2.36 |
CERE Performance Table and Chart
CERE Dollar-cost Average
CERE Trendline Chart
CERE Moving Average Chart
CERE Stock Return Map - See Patterns of Gains and Losses
CERE Stock Returns/Purchase Dates